Pharmaceutical

Who thinks outside the box to get more in it?

阿里彩票登陆平台 www.o1e1e.com.cn We do.

Our pharmaceutical team prides itself on advancing drug delivery with sophisticated science-based solutions. Our global centers of excellence contain the latest equipment and our research scientists and formulators are ready to work with you from concept to commercialization.

Now sold as Klucel™, Ashland introduced hydroxypropylcellulose (HPC) - an excipient that changed the drug delivery platform - to the market 65 years ago. And while others have followed, it was the solvers at Ashland who discovered it. Our full line of products combined with our global research and development capabilities can help deliver your drugs when and where they're needed resulting in better outcomes for patients and pharmaceutical companies alike.

With its significant history in pharmaceuticals and one of the widest available range of products for oral solid-dosage forms Ashland has a solid foundation to help find excipient and formulation solutions for you. Our global manufacturing sites, that operate in accordance with cGMP standards, provide consistently high quality products regardless of origin. As a full-service resource, Ashland can help you bind, coat, dissolve and deliver solutions that can yield better patient outcomes.

an overview of our pharmaceutical focus

Ashland solver and R&D Director of Pharmaceutical and Health & Wellness, Dr. Thomas Durig, discusses our latest innovations and solutions.

 

read more >

  • Oral Solid Dosage Form

    Prescriptions for successful solutions

    While an apple a day keeps the doctor away (and the teacher happy) there comes a time, in almost everyone's life, when medication - in tablet form - is needed.  Our knowledge of the structure function of polymers, combined with our extensive product line can help you bind, coat, dissolve, and effectively deliver complex drug molecules where and when they're needed - making medication easier to swallow.  And, easy to swallow medication often yields better patient compliance,  which, in turn, yields better outcomes for everyone - a winning scenario. From concept to commericialization, working with Ashland makes medicine easy to swallow.

    Ashland is unsurpassed in its ability to develop solutions for effective and efficient solutions to deliver today's complex drug molecules where and when they are needed.  Our centers of excellence and manufacturing sites operate in accordance with cGMP standards. Our various chemistries and technologies are supported by a global team of research and development scientists. Ashland stands ready collaborate with you on new solutions to help take you from concept to commercialization.  Our solutions include:

    • Increasing the solubility of active pharmaceutical ingredients with low or no solubility
    • Designing modified-release products to meet targeted release profiles
    • Reducing tablet size while maintaining active pharmaceutical ingredient load
    • Improving disintegration time of orally disintegrating tablets
    • Understanding implications of continuous manufacturing technology for oral dosage production

    Ongoing research provides a foundation for advanced technical solutions to address these and future formulation and manufacturing challenges. Ashland provides formulators with industry-changing technologies and unique opportunities for research and development collaboration.

     

    Read More >
  • Oral Liquid Dosage Form

    Ashland helps the medicine go down

    A spoonful of sugar may help the medicine go down, but the folks at Ashland, with their expertise in pharmaceutical formulations, know that there's more to it.   Effective drug delivery in liquid form poses some unique challenges with rheology, texture, consistency and stability at the top of the list.  Ashland's promise - always solving™ - inspires our goal of willing to work with you to find new sophisticated solutions to advance drug delivery. With our extensive polymer portfolio, R&D capabilities and testing facilities combined with your complex drug molecues, we can yield solutions that both deliver and improve the bioavailability of needed medication.

    Targeted rheology, texture and stabilization in oral-liquid dosage forms play vital roles in delivery of the pharmaceutical components. The water binding and viscosity modification capacities of many of Ashland’s polymers thicken and suspend in liquids, gels, syrups and semi-solid dosage forms for improved patient satisfaction and shelf life of products. Contact us to learn more.

    Read More >
  • Other Dosage Form

    Solutions that are more than skin deep

    Our solutions are more than skin deep.  Through transdermal and topical  applications, skin can be an effective way to deliver some medications.   Regardless of whether the drug is being delivered via gel, lotion, cream, ointment or foam, features including texture, adhesion,  and spreadability, as well as feel and smell, are important attributes to  consider for optimal patient compliance. For topical and transdermal application, Ashland's pharmacuetical team works with the talented skin care team to find alluring and luxurious ways to effectively and efficiently formulate topical and transdermal applications.

    Topical treatments are administered to skin or mucous membranes to alleviate a variety of conditions. These treatments broadly encompass creams, foams, gels, lotions and ointments. There are a number of sought-after attributes for conferring desired properties to a topical formulation: rheology control, spreadability, adhesion and diffusion control. Ashland offers high-quality cellulose ethers such as Natrosol™ 250 hydroxyethylcellulose, Klucel™ hydroxypropylcellulose and Aqualon™ sodium carboxymethylcellulose to deliver these properties. Some of the topical film formers offered in our skin-care product lines are also suitable for use in topical applications. Plasdone™ povidone is also a good film former for topical applications. Contact us to learn more about our solutions for topical and transdermal applications.

    Read More >

learn more about our solutions


Related Content

  • 1批次婴幼儿配方乳粉检出不合格 涉事企业被立案调查 2019-04-18
  • 共产主义劳动不再是谋生手段就是劳动不再是看着就想笑鼓吹私有制下的责权利所谓平滑对接下的为生存而做资本的雇佣劳动奴隶劳动,而是在共产主义公有制里劳动由于一辈子做 2019-04-18
  • 【专题】省违反中央八项规定精神和“四风”问题线索举报平台 2019-04-18
  • 坚决打好污染防治攻坚战 2019-04-18
  • 国家博物馆举办“无问西东——从丝绸之路到文艺复兴”展 2019-04-17
  • 高校招生广告的创新值得鼓励 2019-04-17
  • 【世界杯·望俄打卦】突尼斯VS英格兰,“欧洲的中国队”英格兰是否突围 2019-04-17
  • 轩辕坛-聚焦汽车两会热点 2019-04-16
  • 中国电信安康分公司60家智慧家庭便民服务中心盛大开业中国电信安康-最新活动 2019-04-16
  • 儿童掉进冰窟 小伙用双手砸出“生命通道” 2019-04-16
  • 【专题】加油,宝贝! 2019-04-15
  • 西部网评论频道——《华山论见》投稿启事 2019-04-15
  • 国家移民管理局要求全国边检机关确保中国公民出入境通关排队不超过30分钟 2019-04-14
  • 回复@海之宁:你想自主劳动?全民所有的生产资料凭啥让你自主? 2019-04-14
  • 议会“争夺”决定权 英政府“脱欧”方案再受阻 2019-04-14
  • 690| 283| 355| 329| 113| 333| 839| 76| 396| 935|